Page last updated: 2024-08-26

imipenem, anhydrous and Cystic Fibrosis

imipenem, anhydrous has been researched along with Cystic Fibrosis in 39 studies

Research

Studies (39)

Timeframe	Studies, this research(%)	All Research%
pre-1990	8 (20.51)	18.7374
1990's	10 (25.64)	18.2507
2000's	7 (17.95)	29.6817
2010's	11 (28.21)	24.3611
2020's	3 (7.69)	2.80

Authors

Authors	Studies
Alba, L; Chen, Y; Garber, E; Saiman, L; Tabibi, S; Zhou, J	1
Juan, C; Maciá, MD; Mena, A; Mulet, X; Oliver, A; Pérez, JL	1
Beceiro, A; Bou, G; Doumith, M; Livermore, DM; Tomás, M; Turton, JF; Warner, M; Woodford, N	1
Bottery, MJ; Friman, VP; Quinn, AM; Thompson, H	1
Dargahi, Z; Etemad, A; Ghasemian, E; Hashemian, M; Kaviar, VH; Lohrasbi, A; Saadh, MJ	1
Belz, DC; Deck, DH; Ignatius, EH; Lamichhane, G; Lippincott, CK; Nicklas, DA; Panthi, CM; Rimal, B; Serio, AW	1
Caspar, Y; Courtois, N; Maurin, M	1
Abdalhamid, B; Fowler, RC; Hanson, ND; Harrison, LB; Selmecki, A	1
Bellulo, S; Degand, N; Diene, SM; Dubus, JC; L'homme, T; Leroy, S; Mely, L; Rolain, JM; Stremler, N	1
Arthur, M; Dubée, V; Gaillard, JL; Gutmann, L; Herrmann, JL; Heym, B; Lavollay, M; Mainardi, JL	1
Al-Mathkhury, HJ; Kuchma, SL; Musafer, HK; Naimie, AA; O'Toole, GA; Schwartzman, JD	1
Diene, SM; Gupta, SK; Rolain, JM; Sharma, P	1
Boutoille, D; Bretonnière, C; Caillon, J; Guitton, C; Jacqueline, C; Maitte, A; Potel, G	1
Girlich, D; Kolb, A; Naas, T; Nordmann, P	1
Baquero, F; Cantón, R; del Campo, R; García-Castillo, M; Morosini, MI; Turrientes, MC; Zamora, J	1
Barbeito Castiñeiras, G; Martín Romero Domínguez, M; Martínez-Lamas, L; Palacios Bartolomé, A; Pérez Del Molino Bernal, ML; Rabade Castedo, C	1
Arıkan Ayyıldız, Z; Bahar, IH; Fırıncı, F; Karaman, M	1
Jones, RN; Mutnick, AH; Turner, PJ	1
Kadry, AA	1
Neu, HC; Prince, AS	1
Ballestero, S; Baquero, F; Escobar, H; Fernández-Rodríguez, A; Pérez-Díaz, JC; Villaverde, R	1
Bingen, E; Bonacorsi, S; Fitoussi, F; Lhopital, S	1
Christenson, JC; Daly, JA; Korgenski, EK	1
Bingen, E; Bonacorsi, S; Brahimi, N; Gérardin, M; Lebourgeois, M; Mariani-Kurkdjian, P; Munck, A; Navarro, J	1
Dotti, M; Giacchino, M; Pavesio, D; Pecco, P	1
Dyke, JW; Hay, MB; Kumar, A; Maier, GA	1
Bingen, E; Denamur, E; Elion, J; Foucaud, P; Goullet, P; Lambert-Zechovsky, N; Navarro, J; Picard, B	1
Godard, C; Leroy, J; Michel-Briand, Y	1
Croizé, J; Hirtz, P; Le Noc, P; Recule, C	1
Greene, LM; Harwood, IR; Kozakowski-Koch, JA; Rasor, JS	1
Goldmann, DA; Lambert, KG; Macone, AB; O'Rourke, EJ; Parsonnet, KC	1
Ansorg, R; Müller, KD; Wiora, J	1
McCracken, GH; Mustafa, MM	1
Gordon, RC; Kumar, A; Wofford-McQueen, R	1
Bentzon, MW; Høiby, N; Jensen, T; Koch, C; Pedersen, SS; Pressler, T; Rosdahl, VT	1
Bergan, T; Malmborg, AS; Michalsen, H; Storrøsten, OT; Strandvik, B; Wretlind, B	1
Agueda, L; Chabanon, G; Dournes, JL; Lapchine, L; Marty, N	1
Blumer, JL; Myers, CM; O'Brien, CA; Reed, MD; Stern, RC; Yamashita, TS	1
Bentzon, MW; Høiby, N; Koch, C; Pedersen, SS; Pressler, T	1

Reviews

2 review(s) available for imipenem, anhydrous and Cystic Fibrosis

Article	Year
The Status of Carbapenem Resistance in Cystic Fibrosis: A Systematic Review and Meta-Analysis. The Yale journal of biology and medicine, 2022, Volume: 95, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Cystic Fibrosis; Doripenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2022
Antimicrobial agents in pediatrics. Infectious disease clinics of North America, 1989, Volume: 3, Issue:3 Topics: Adolescent; Adult; Age Factors; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Child; Child, Preschool; Cilastatin; Cystic Fibrosis; Humans; Imipenem; Infant; Tissue Distribution	1989

Trials

1 trial(s) available for imipenem, anhydrous and Cystic Fibrosis

Article	Year
Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients. The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:1 Topics: Adolescent; Adult; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cystic Fibrosis; Drug Resistance, Microbial; Evaluation Studies as Topic; Humans; Imipenem; Infant; Infant, Newborn; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Species Specificity; Thienamycins	1996

Article

Year

Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients.

The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:1

Topics: Adolescent; Adult; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cystic Fibrosis; Drug Resistance, Microbial; Evaluation Studies as Topic; Humans; Imipenem; Infant; Infant, Newborn; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Species Specificity; Thienamycins

1996

Other Studies

36 other study(ies) available for imipenem, anhydrous and Cystic Fibrosis

Article	Year
Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3 Topics: Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests	2007
Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4 Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Biofilms; Cefepime; Cephalosporins; Ciprofloxacin; Cystic Fibrosis; DNA-Binding Proteins; Humans; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; MutS DNA Mismatch-Binding Protein; Pseudomonas aeruginosa; Transcription Factors	2009
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Membrane Transport Proteins; Mutation; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation	2010
Resistance evolution can disrupt antibiotic exposure protection through competitive exclusion of the protective species. The ISME journal, 2022, Volume: 16, Issue:10 Topics: Anti-Bacterial Agents; Cystic Fibrosis; Humans; Imipenem; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Pyocyanine	2022
Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease. mSphere, 2023, 04-20, Volume: 8, Issue:2 Topics: Animals; Anti-Bacterial Agents; Cefoxitin; Cystic Fibrosis; Imipenem; Linezolid; Mice; Microbial Sensitivity Tests; Mycobacterium abscessus; Rifabutin; Tetracyclines	2023
Phenotypic and genetic resistance traits of Pseudomonas aeruginosa strains infecting cystic fibrosis patients: A French cohort study. International journal of antimicrobial agents, 2018, Volume: 52, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Ceftazidime; Cephalosporinase; Cloxacillin; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; France; Humans; Imipenem; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa; Pseudomonas Infections	2018
lptG contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of Pseudomonas aeruginosa. MicrobiologyOpen, 2019, Volume: 8, Issue:11 Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Cell Membrane; Codon, Nonsense; Cystic Fibrosis; Doripenem; Drug Resistance, Bacterial; Electrophoresis, Polyacrylamide Gel; Humans; Imipenem; Lipopolysaccharides; Meropenem; Microbial Sensitivity Tests; Mutation, Missense; Permeability; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Whole Genome Sequencing	2019
ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France. International journal of antimicrobial agents, 2013, Volume: 42, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cystic Fibrosis; DNA Transposable Elements; Drug Resistance, Bacterial; Female; France; Gene Expression Regulation, Bacterial; Humans; Imipenem; Inverted Repeat Sequences; Microbial Sensitivity Tests; Molecular Sequence Data; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Young Adult	2013
In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:5 Topics: Anti-Bacterial Agents; Cefoxitin; Colony Count, Microbial; Cystic Fibrosis; Humans; Imipenem; Microbial Sensitivity Tests; Nontuberculous Mycobacteria; Respiratory Tract Infections	2014
Investigating the link between imipenem resistance and biofilm formation by Pseudomonas aeruginosa. Microbial ecology, 2014, Volume: 68, Issue:1 Topics: Anti-Bacterial Agents; Biofilms; Cystic Fibrosis; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Imipenem; Mutation; Porins; Pseudomonas aeruginosa; Sputum	2014
Whole-genome sequence of Chryseobacterium oranimense, a colistin-resistant bacterium isolated from a cystic fibrosis patient in France. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; beta-Lactamases; Chryseobacterium; Colistin; Cystic Fibrosis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Flavobacteriaceae Infections; France; Humans; Imipenem; Mutation; Phylogeny; Sequence Analysis, DNA	2015
MIC score, a new tool to compare bacterial susceptibility to antibiotics application to the comparison of susceptibility to different penems of clinical strains of Pseudomonas aeruginosa. The Journal of antibiotics, 2016, Volume: 69, Issue:11 Topics: Anti-Bacterial Agents; Carbapenems; Cystic Fibrosis; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	2016
Characterization of regulatory element Rp3 of regulation of beta-lactamases from Ralstonia pickettii. FEMS microbiology letters, 2009, Volume: 301, Issue:1 Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Cystic Fibrosis; DNA, Bacterial; Gene Expression Regulation, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Molecular Sequence Data; Promoter Regions, Genetic; Ralstonia pickettii; Transcription Factors; Transcription Initiation Site; Transcriptional Activation	2009
Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2011, Volume: 17, Issue:5 Topics: Anti-Bacterial Agents; Biofilms; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Bacterial; Genetic Variation; Humans; Imipenem; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory System; Tobramycin	2011
[Pandoraea sputorum colonization in a patient with cystic fibrosis]. Archivos de bronconeumologia, 2011, Volume: 47, Issue:11 Topics: Anti-Bacterial Agents; Bronchiectasis; Burkholderia cepacia complex; Burkholderia Infections; Child; Cystic Fibrosis; Cytokines; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; Humans; Imipenem; Pneumonia, Bacterial; Pseudomonas Infections; Sputum; Superinfection; Virulence	2011
[Effects of Imipenem, Tobramycin and Curcumin on Biofilm Formation of Pseudomonas aeruginosa Strains]. Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:1 Topics: Anti-Bacterial Agents; Biofilms; Curcumin; Cystic Fibrosis; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2013
Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection. Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:3 Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Critical Care; Cystic Fibrosis; Data Collection; Drug Resistance, Bacterial; Europe; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Population Surveillance; Proteus Infections; Proteus mirabilis; Tazobactam; Thienamycins	2002
Lack of efflux mechanism in a clinical isolate of Pseudomonas aeruginosa highly resistant to beta-lactams and imipenem. Folia microbiologica, 2003, Volume: 48, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Biological Transport, Active; Cefepime; Ceftazidime; Ceftriaxone; Cell Membrane Permeability; Cephalosporins; Conjugation, Genetic; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Electrophoresis, Polyacrylamide Gel; Genes, Bacterial; Humans; Imipenem; Membrane Transport Proteins; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa	2003
Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. Antimicrobial agents and chemotherapy, 1981, Volume: 20, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections	1981
Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:2 Topics: Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Rifampin; Thienamycins; Tobramycin	1999
In vitro activity of meropenem, imipenem, cefepime and ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients. The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:6 Topics: Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins	2000
Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization. Pediatric pulmonology, 2001, Volume: 32, Issue:4 Topics: Administration, Inhalation; Administration, Oral; Ceftazidime; Child; Child, Preschool; Chronic Disease; Colistin; Colony Count, Microbial; Cystic Fibrosis; DNA, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Imipenem; Infant; Male; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Assessment; Tobramycin	2001
Imipenem use in serious childhood infections. Journal of chemotherapy (Florence, Italy), 1991, Volume: 3 Suppl 1 Topics: Antineoplastic Agents; Bacterial Infections; Child; Cystic Fibrosis; Humans; Imipenem; Neoplasms; Neutropenia; Retrospective Studies; Surgical Wound Infection; Thienamycins; Treatment Outcome	1991
Post-antibiotic effect of ceftazidime, ciprofloxacin, imipenem, piperacillin and tobramycin for Pseudomonas cepacia. The Journal of antimicrobial chemotherapy, 1992, Volume: 30, Issue:5 Topics: Burkholderia cepacia; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Tobramycin	1992
Molecular epidemiological analysis of Pseudomonas aeruginosa strains causing failure of antibiotic therapy in cystic fibrosis patients. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1992, Volume: 11, Issue:5 Topics: Azlocillin; Bacterial Typing Techniques; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Drug Therapy, Combination; Esterases; Humans; Imipenem; Polymorphism, Restriction Fragment Length; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections	1992
Characterization of imipenem-resistant Pseudomonas aeruginosa strains from cystic fibrosis patients. The Journal of antimicrobial chemotherapy, 1992, Volume: 30, Issue:5 Topics: Cilastatin; Cystic Fibrosis; DNA, Bacterial; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Pseudomonas aeruginosa	1992
[Pseudomonas aeruginosa and imipenem: correlation between membrane protein D2 and resistance in fifteen strains isolated from patients with mucoviscidosis]. Pathologie-biologie, 1992, Volume: 40, Issue:5 Topics: Bacterial Outer Membrane Proteins; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Humans; Imipenem; In Vitro Techniques; Molecular Weight; Pseudomonas aeruginosa; Pseudomonas Infections	1992
New peripherally inserted midline catheter: a better alternative for intravenous antibiotic therapy in patients with cystic fibrosis. Pediatric pulmonology, 1992, Volume: 12, Issue:4 Topics: Adolescent; Adult; Catheterization, Peripheral; Catheters, Indwelling; Ceftazidime; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Elbow; Female; Humans; Imipenem; Infusions, Intravenous; Male; Piperacillin; Time Factors; Tobramycin	1992
False resistance to imipenem with a microdilution susceptibility testing system. Journal of clinical microbiology, 1991, Volume: 29, Issue:4 Topics: Cystic Fibrosis; Drug Resistance, Microbial; Escherichia coli; False Positive Reactions; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quality Control; Sensitivity and Specificity	1991
Comparison of inhibitory and bactericidal activity of antipseudomonal antibiotics against Pseudomonas aeruginosa isolates from cystic fibrosis patients. Chemotherapy, 1990, Volume: 36, Issue:3 Topics: Amikacin; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin	1990
Ciprofloxacin, imipenem and rifampicin: in-vitro synergy of two and three drug combinations against Pseudomonas cepacia. The Journal of antimicrobial chemotherapy, 1989, Volume: 23, Issue:6 Topics: Ciprofloxacin; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas; Rifampin; Sputum	1989
Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis. The Journal of antimicrobial chemotherapy, 1987, Volume: 19, Issue:1 Topics: Adolescent; Adult; Anti-Bacterial Agents; Bronchopneumonia; Child; Chronic Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Cystic Fibrosis; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Kinetics; Male; Microbial Sensitivity Tests; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Thienamycins; Tobramycin	1987
Imipenem/cilastatin, an alternative treatment of pseudomonas infection in cystic fibrosis. The Journal of antimicrobial chemotherapy, 1988, Volume: 21, Issue:4 Topics: Adolescent; Adult; Child; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Cystic Fibrosis; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Thienamycins	1988
Effects of five antibiotics on adhesion and haemagglutinating properties of Pseudomonas aeruginosa isolated from cystic fibrosis patients. Drugs under experimental and clinical research, 1988, Volume: 14, Issue:10 Topics: Animals; Anti-Bacterial Agents; Bacterial Adhesion; Cefsulodin; Ceftazidime; Cystic Fibrosis; Guinea Pigs; Hemagglutination; Humans; Imipenem; Microscopy, Electron; Moxalactam; Pefloxacin; Pseudomonas aeruginosa; Sputum	1988
Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis. Antimicrobial agents and chemotherapy, 1985, Volume: 27, Issue:4 Topics: Anti-Bacterial Agents; Child; Chromatography, High Pressure Liquid; Cilastatin; Creatinine; Cyclopropanes; Cystic Fibrosis; Dipeptidases; Drug Combinations; Humans; Imipenem; Kinetics; Thienamycins	1985
Imipenem/cilastatin treatment of multiresistant Pseudomonas aeruginosa lung infection in cystic fibrosis. The Journal of antimicrobial chemotherapy, 1985, Volume: 16, Issue:5 Topics: Adolescent; Adult; Child; Cilastatin; Cyclopropanes; Cystic Fibrosis; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Imipenem; Lung Diseases; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	1985